Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
The Clinical Respiratory Journal|December 28, 2016
Well-differentiated bronchial neuroendocrine tumors: Clinical management and outcomes in 105 patientsMarinos Pericleous, Anna Karpathakis, Christos Toumpanakis, et al.
Case Reports in Oncology|June 29, 2012
Gastric mixed adenoneuroendocrine carcinoma with a trilineage cell differentiation: case report and review of the literatureMarinos Pericleous, Christos Toumpanakis, Heather Lumgair, et al.
Molecular & Cellular Proteomics : MCP|December 19, 2009
Identification of Mac-2-binding protein as a putative marker of neuroendocrine tumors from the analysis of cell line secretomesRajaventhan Srirajaskanthan, Martyn E Caplin, Mark G Waugh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Circulating tumor cells as prognostic markers in neuroendocrine tumorsMohid S Khan, Amy Kirkwood, Theodora Tsigani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 9, 2013
Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumorsDamian Wild, Jamshed B Bomanji, Pascal Benkert, et al.
Clinical Nuclear Medicine|December 7, 2021
The Combined Interpretation of 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT in Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Classification System With Prognostic ImpactAimee R Hayes, Luke Furtado O'Mahony, Ann-Marie Quigley, et al.
Oncology Reports|March 10, 2005
Expression of c-kit (CD117) in neuroendocrine tumours--a target for therapy?Virginia Kostoula, Korsa Khan, Kay Savage, et al.
Neuroendocrinology|April 8, 2006
Intertumoural variability in functional imaging within patients suffering from neuroendocrine tumours. An observational, cross-sectional studyAnn-Marie Quigley, John R Buscombe, Tahir Shah, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 9, 2021
177Lu-DOTATATE in older patients with metastatic neuroendocrine tumours: safety, efficacy and health-related quality of lifeLuohai Chen, Shaunak Navalkissoor, Ann-Marie Quigley, et al.
Radiology|September 30, 2005
Large-volume liver metastases from neuroendocrine tumors: hepatic intraarterial 90Y-DOTA-lanreotide as effective palliative therapyMary K G McStay, Dave Maudgil, Martin Williams, et al.
Pageof 8